Home » Authors » Aaron Lorenzo

Articles by Aaron Lorenzo

Critical Therapeutics Files For Estimated $103.5M IPO

March 22, 2004

By Aaron Lorenzo

Antigenics Pockets $14.25M For Sale Of Feline Leukemia Vaccine

March 19, 2004

By Aaron Lorenzo

Antigenics Pockets $14.25M For Sale Of Feline Leukemia Vaccine

March 19, 2004

By Aaron Lorenzo

Tercica Completes IPO With Below-Range Share Pricing

March 18, 2004

By Aaron Lorenzo

Tercica Completes IPO With Below-Range Share Pricing

March 18, 2004

By Aaron Lorenzo

From Services To Cancer: Semafore's Focus Change

March 17, 2004

By Aaron Lorenzo

From Services To Cancer: Semafore's Focus Change

March 17, 2004

By Aaron Lorenzo

ChemoCentryx, Forest Form Partnership On Chemokines

March 16, 2004

By Aaron Lorenzo

ChemoCentryx, Forest Form Partnership On Chemokines

March 16, 2004

By Aaron Lorenzo

Series C In The Past, Momenta Files For Initial Public Offering

March 15, 2004

By Aaron Lorenzo

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan. 10, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for January 10, 2025
Type 1 diabetes breakthrough? Sana threads key ‘islet,’ SC-451 to advance
BioWorld
Sana Biotechnology Inc. CEO Steve Harr said “cool and transformative science” led to his firm’s latest strides in type 1 diabetes, and the “very generalizable...
Australia’s Celosia heads toward clinic with gene therapy for ALS
BioWorld
After raising AU$16.75 million (US$10.4 million) in a series A round, Celosia Therapeutics Pty Ltd. is heading toward the clinic with its novel gene therapy that...
Sangamo stock plunges as Pfizer leaves hemophilia partnership
BioWorld
Sangamo Therapeutics Inc.’s stock sank sharply on the last day of 2025 as Pfizer Inc. handed back the rights to their collaborative gene therapy hemophilia A...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.